from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1558/-

LFCtreatmentdescriptionclass of inhibitor

-0.350

Amikacinug/mL Amikacintranslation

0.947

Cap5-10ug/mL Capreomycintranslation

1.851

Rox10-50 ug/mL Roxithromycintranslation

0.399

SM2-5 ug/mL Streptomycintranslation

0.195

Tet5-10 ug/mL Tetracyclinetranslation

0.566

Rif0.2-5ug/mL Rifampicintranscription

0.147

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.127

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.968

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.034

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.390

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.539

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.280

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.084

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.334

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.022

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.435

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.475

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.826

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.894

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.759

KCN5-20 ug/mL Potassium cyaniderespiration

-0.134

NaN30.2-2 mM Sodium aziderespiration

1.044

Nigericin50 uM Nigericinrespiration

-0.863

TRC10-150 ug/mL Triclosanrespiration

-0.743

TRZ10-25 ug/mL Thioridazinerespiration

0.431

Valinomycin0.5-10 uM Valinomycinrespiration

1.219

ZnSO42 mM ZnSO4respiration

1.291

menadione6-10 ug/mL Menadionerespiration

0.310

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.139

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.193

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.650

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.187

NRP_1Non-replicating persistence stage 1dosRassociated

0.456

Amp0.2mg/mL AmpicillincellWall

0.242

Cephalexin20-100 ug/mL CephalexincellWall

0.392

Cerulenin0.32-5 ug/mL CerulenincellWall

0.458

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.627

EMB10-20 ug/mL EthambutolcellWall

1.008

Eta12-40 ug/mL EthionamidecellWall

1.606

INH0.2-0.4 ug/mL IsoniazidcellWall

0.557

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.519

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.371

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.856

BZA0.12 mg/mL BenzamidearomaticAmides

-0.653

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.414

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.058

H2O24 mM hydrogen peroxideDNAdamaging

0.097

Levo10 ug/mL LevofloxacinDNAdamaging

0.260

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.248

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.267

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.303

UVUV-irradiationDNAdamaging

0.842

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.157

Antimycin12.5-50 ug/mL Antimycin A?

-0.204

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.202

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.366

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.286

PA8240.2-2 ug/mL PA-824?

-0.234

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.100

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.426

Verapamil50 uM Verapamil?

-0.653

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.437

methoxatin10-20 ug/mL Methoxatin?